Health Economics Review

Papers
(The H4-Index of Health Economics Review is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea94
The cost of implementing measles campaign in Nigeria: comparing the stand-alone and the integrated strategy85
The healthcare costs of increased body mass index–evidence from The Trøndelag Health Study49
Contracting with sequential care providers41
Evaluating a capacity development intervention in health economics among producers and users of evidence in Nigeria: a case study in Getting Research Into Policy and Practice (GRIPP) in Anambra State38
Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model37
Building an integrated healthcare system of China: an assessment of coupling coordination between disease prevention, medical services, and healthcare financing from 2012 to 202129
Utilization of maternal health facilities and rural women’s well-being: towards the attainment of sustainable development goals28
End-of-life expenditure on health care for the older population: a scoping review27
Evaluating the costs of adverse drug events in hospitalized patients: a systematic review27
The economic impact of anastomotic leak after colorectal cancer surgery23
Impact of diabetes diagnosis on dental care utilization: evidence from Finland19
Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018–2019)18
Policies and cost analyses of voluntary assisted dying (VAD) laws – a mapping review & analysis17
Distributed education enables distributed economic impact: the economic contribution of the Northern Ontario School of Medicine to communities in Canada17
Correction: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan16
Health insurance coverage in Ethiopia: financial protection in the Era of sustainable development goals (SDGs)16
0.048523187637329